Cinemark Holdings (FRA:ZZA) Research & Development: €0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZZA Cinemark Holdings Inc FRA:ZZA
72 GF Score
Price €30.20
GF Value €26.82
! 5 Warning Signs
View Full Analysis

What is Cinemark Holdings Research & Development?

Cinemark Holdings FRA:ZZA -0.66% 72 Research & Development is €0 Mil as of Jun. 2026. GuruFocus rates FRA:ZZA with a GF Score™ of 72/100 and a GF Value™ of €26.82. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cinemark Holdings's Research & Development for the three months ended in Jun. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was €0 Mil.

Cinemark Holdings  (FRA:ZZA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cinemark Holdings Research & Development Related Terms

Cinemark Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Cinemark Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cinemark Holdings Research & Development Chart

Cinemark Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cinemark Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:ZZA
72GF Score
Cinemark Holdings Inc FRA:ZZA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cinemark Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Cinemark Holdings (FRA:ZZA) has a Research & Development of €0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Cinemark Holdings and its competitors.
Is Cinemark Holdings' Research & Development too high?
Cinemark Holdings' current Research & Development is €0 Mil. Overall, Cinemark Holdings has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Cinemark Holdings' Research & Development compare to LION and MANU?
Cinemark Holdings' Research & Development of €0 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Media - Diversified company?
A good Research & Development depends on the Media - Diversified industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cinemark Holdings and its competitors. Cinemark Holdings's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cinemark Holdings stock overvalued right now?
Cinemark Holdings (FRA:ZZA) has a current Research & Development of €0 Mil. The stock's GF Value™ is €26.82, compared to a current price of €30.20 — trading 12.6% above its estimated fair value. The current Research & Development is €0 Mil. Cinemark Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cinemark Holdings (FRA:ZZA), the current Research & Development is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cinemark Holdings (FRA:ZZA) Overvalued in 2026?

Based on GuruFocus' analysis, Cinemark Holdings stock appears to be overvalued. The current stock price of €30.20 is trading 12.6% above its estimated GF Value™ of €26.82.

Key valuation signals for FRA:ZZA:

  • Research & Development: €0 Mil
  • GF Value™: €26.82 vs. price of €30.20 (12.6% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the FRA:ZZA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cinemark Holdings Business Description

Other Exchanges CNK:USACNK:Mexico
Address 3900 Dallas Parkway, Plano, TX, USA, 75093
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.
72GF Score

Get the complete analysis for FRA:ZZA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€30.20
Price
€26.82
GF Value